A Step Toward Trump's ‘Big, Beautiful Bill'
From the The Morning Dispatch on The Dispatch
Happy Thursday! It turns out Duo, the owl mascot for the language-learning app Duolingo, faked its 'death' earlier this month in what turned out to be an elaborate marketing ploy. That's the last time we trust the word of a fictional green avian.
Hamas returned the bodies of four slain hostages to Israel early Thursday morning as part of the U.S.-brokered ceasefire deal. Forensic scientists confirmed that the group included Itzik Elgarat, Ohad Yahalomi, Tsahi Idan, and Shlomo Mantzur—the oldest hostage in Gaza at 86 years old at the time of his abduction. Meanwhile, Israel began the release of more than 600 Palestinian prisoners, 151 of whom had been serving life sentences or long prison terms, into the West Bank and Gaza. The exchange marked the final handover of the first phase of the three-phase ceasefire between Israel and Hamas. Negotiators have yet to agree to terms for a second stage of the deal.
A new report by the International Atomic Energy Agency (IAEA)—the United Nations' nuclear watchdog—indicated that Iran grew its supply of uranium enriched to close to weapons grade by 50 percent in the last three months. The confidential report, which was seen by several news outlets on Wednesday, found that Iran had increased its stockpile of uranium enriched to 60 percent from 182 kilograms to 274 kilograms in the last quarter. The country is now enriching enough uranium for one nuclear bomb each month. 'The significantly increased production and accumulation of high enriched uranium by Iran, the only non-nuclear weapon State to produce such nuclear material, is of serious concern,' the report stated.
Texas health officials confirmed Wednesday that an unvaccinated school-aged child died this week from measles—the first death from the disease the country has seen in a decade. The death comes amid a measles outbreak in Texas, where at least 124 people—the vast majority of whom are unvaccinated children and teenagers—have been infected and 18 people have been hospitalized. Secretary of Health and Human Services Robert F. Kennedy Jr. tried to downplay the significance of the outbreak on Wednesday, saying the outbreaks are 'not unusual' and that the hospitalizations were 'mainly for quarantine.' Local hospital representatives said the patients were admitted for respiratory issues, not to quarantine. Kennedy also stated incorrectly that two people had died.
President Donald Trump said Wednesday that his administration is preparing to impose sweeping tariffs on the European Union (EU). 'We have made a decision and we'll be announcing it very soon,' the president said from the first Cabinet meeting of his second term. 'It'll be 25 percent generally speaking, and that will be on cars and all other things.' Meanwhile, the European Commission threatened to take retaliatory steps. 'The EU will react firmly and immediately against unjustified barriers to free and fair trade,' it said in a statement. The bloc is reportedly preparing a list of U.S. goods to impose tariffs on in response.
Supreme Court Chief Justice John Roberts temporarily paused a federal judge's order compelling the State Department and the U.S. Agency for International Development (USAID) to end their freeze on the disbursement of foreign aid by 11:59 p.m. ET on Wednesday. The Trump administration, meanwhile, indicated plans on Wednesday night to make sweeping cuts to U.S. foreign assistance programs, including ending nearly 10,000 grants and contracts awarded by the State Department and USAID. The changes, outlined in a court filing by administration attorneys and an internal memo, would save the U.S. government an estimated $58.2 billion, a State Department spokesman claimed Wednesday.
The heads of the offices of Personnel Management and Management and Budget shared a memo with executive branch agencies on Wednesdays directing them to prepare for mass firings or 'large-scale reductions in force.' Agency heads were directed to submit 'reorganization plans' by March 13, with a 'focus on the maximum elimination of functions that are not statutorily mandated while driving the highest-quality, most efficient delivery of their statutorily-required function.' The memo did not include a specific percentage of positions to be eliminated, but Trump said Wednesday that the Environmental Protection Agency is planning to cut its workforce by 65 percent.
President Donald Trump has repeatedly said that he wants to see his tax and spending priorities passed in 'one big, beautiful bill' this year. On Tuesday night, House Republicans took one big, beautiful stride toward that goal with the passage of a budget resolution calling for hefty spending and tax cuts.
But it's just the beginning of a long and bumpy road for budget negotiations. The resolution's passage, on a near-party-line vote of 217-215, is just the first step in shepherding through a budget for the next fiscal year.
To see Trump's single bill realized, House Speaker Mike Johnson will need to corral not only his narrow Republican majority in the lower chamber but also the Senate. GOP leadership is counting on the budget to pass as part of the reconciliation process later this year, allowing it to bypass a Senate filibuster by Democrats. But for that to happen, both chambers of Congress must agree on the eventual bill's framework.
At the very least, budget negotiations now have momentum. Following dramatic scenes in which congressional leadership, believing they lacked enough support, canceled a planned Tuesday night vote only to abruptly call lawmakers back to the Capitol 13 minutes later, Republicans are relieved. 'A lot of work yet to be done, but we're going to celebrate tonight, and we'll roll up our sleeves and get right back at it in the morning,' Johnson told reporters after the vote.
In addition to calling for $4.5 trillion in tax cuts and $2 trillion in spending cuts over the next decade, the budget resolution asks for a $4 trillion increase in the debt ceiling. The package will effectively extend the Tax Cuts and Jobs Act (TCJA), Trump's main legislative achievement from his first term, for 10 years. But Manhattan Institute Senior Fellow Jessica Riedl pointed out earlier this month in our pages that the net effect will be to add more than $3 trillion to the national deficit over the next decade.
Passing a budget through reconciliation has certain requirements, laid out in the 1974 Congressional Budget Act. Both the House and Senate must pass a budget resolution setting tax, spending, and debt limit targets, which are then turned into specific proposals by congressional committees. Once the legislative specifics are hammered out and both chambers agree, the House and Senate Budget committees work to combine the two into a single 'omnibus' bill, which can then be passed under normal House voting rules and by a simple majority in the Senate, getting around the delays posed by a filibuster (which requires 60 votes to break). However, reconciliation is usually only used once per year, cannot affect Social Security spending, and cannot increase the deficit outside a 10-year window.
Even under this streamlined framework, the politics of the proposed budget are iffy, with Social Security off the table, boosting defense spending a priority, and some Republicans, including Trump, saying they refuse to touch Medicaid. But last week Trump endorsed the GOP plan even though the resolution would instruct the House Energy and Commerce Committee, which oversees Medicare and Medicaid, to find $880 billion in spending cuts. A few hundred billion can be found by reversing Biden-era regulations and cutting in other areas, but the bulk of the savings will almost certainly have to come from the $839 billion annually spent on Medicaid, despite Trump's previous promises.
These cuts threatened to upend Johnson's budget plan in the lead-up to its passage. 'I'm really concerned about this,' Rep. David Valadao, a moderate Republican who represents a swing district in California, said last week. More than 60 percent of Valadao's constituents are Medicaid recipients, according to health data compiled by New York University's Grossman School of Medicine. And a review by Politico found that at least 10 other Republicans representing competitive districts are in similarly tight positions.
Meanwhile, some fiscal conservatives had argued the resolution's spending cuts didn't go far enough. 'We promised the people we're gonna have cuts, and then we're just gonna turn right around and spend the money at the Pentagon,' Rep. Tim Burchett, a Republican from Tennessee, said Tuesday. 'The war pimps will get theirs no matter what anyway.' Reps. Victoria Spartz of Indiana, Warren Davidson of Ohio, and Thomas Massie of Kentucky also voiced concerns that the budget plan would add to the federal deficit.
GOP leaders reportedly assuaged the fears of moderates concerned by possible cuts to Medicaid during a closed-door meeting on Monday. 'There's a lot of space to address the issue without hurting beneficiaries,' such as 'hundreds of billions' spent on waste, fraud, and abuse, said Rep. Nicole Malliotakis, a Republican from New York.
That left the fiscal hardliners. Calls from Trump were reportedly enough to flip Spartz and Burchett. 'This is the best I could get to,' Burchett said Wednesday. 'I've often said you're either at the table or on the menu, and I needed to be at the table.' Davidson also told reporters that he had 'received assurances' that the final bill would include sufficient spending cuts. In the end, Massie provided the only GOP vote against the resolution, citing his concerns about the debt.
But now the question is what happens in the Senate. On Wednesday, Republican senators were blunt: as currently constructed, they won't accept the proposed framework, which is why last week the chamber passed a fallback bill written by Sen. Lindsey Graham, a Republican from South Carolina, that avoids the question of tax cuts. The measure includes $175 billion in new funds for immigration enforcement and $150 billion to strengthen military supply chains. It also directs Senate committees to find spending cuts to offset the costs.
Some senators, echoing House moderates, are concerned about slashing Medicaid the way the House's bill directs. 'I realize it's just a broad instruction to that committee, but I think there will be concerns about that and what that may lead to,' said Sen. Josh Hawley, a Republican from Missouri. Others pointed out that even if all of the cuts envisaged in the bill were enacted, it would still increase the deficit. 'Acquiescing to a $4 trillion increase in the debt ceiling is for me a non-starter,' said Sen. Rand Paul, a Republican from Kentucky. Sen. Roger Wicker, a Republican from Mississippi, also told reporters that the resolution did not reduce spending by enough.
Others, including Senate Majority Leader John Thune, a South Dakota Republican, are insisting that the new budget make the 2017 Tax Cuts and Jobs Act permanent—something the House resolution does not do. It all could come down to the technical way those cuts are measured, as Charles Hilu explained in a piece for the site earlier this week.
A Wednesday White House meeting between Treasury Secretary Scott Bessent, National Economic Council Director Kevin Hassett, and congressional leaders may have produced enough common ground to get over that hurdle, but much remains to be negotiated over the coming months, with Johnson aiming for the ambitious deadline of April. Congress must also find a way to avert a looming government shutdown in March. But for now, the one-two punch of Trump and Johnson, working to bring together disparate factions of the House, has prevailed. It's a sign that almost no Republican, whether in the Senate or the House, is yet willing to buck Trump's agenda.
But eventually, tough talk and bluster will run into concrete fiscal realities. 'Big First Step Win for Speaker Mike Johnson, and AMERICA. Now let's start to BALANCE THE BUDGET. IT CAN BE DONE!!!,' Trump wrote on his Truth Social account Thursday morning. We'll find out soon if he's right.
Thousands of mourners lined the streets of Israel on Wednesday to watch the funeral procession of Shiri Bibas and her 4-year-old and 9-month-old sons, Ariel and Kfir, who were taken hostage by terrorists on October 7, 2023, and murdered in Gaza. Yarden Bibas, who was kidnapped separately and released earlier this month, delivered a heart-breaking eulogy for his wife and children yesterday. 'Mishmish, who will help me make decisions now?' Yarden said, addressing his wife. 'How am I supposed to make decisions without you? Do you remember our last decision together? In the safe room, I asked if we should 'fight or surrender.' You said fight, so I fought. Shiri, I'm sorry I couldn't protect you all. … Shiri, people tell me they'll always be by my side, but they're not you. Shiri, this is the closest I've been to you since October 7th, and I can't kiss or hug you, and it's breaking me! Shiri, please watch over me… Protect me from bad decisions. Shield me from harmful things and protect me from myself. Guard me so I don't sink into darkness. Mishmish, I love you!'
Jeff Bezos in a note to Washington Post employees on Wednesday:
We are going to be writing every day in support and defense of two pillars: personal liberties and free markets. We'll cover other topics too of course, but viewpoints opposing those pillars will be left to be published by others.
Politico: Gavin Newsom Is Launching His Own Podcast—And Inviting MAGA Favorites
Rep. Joe Wilson, a South Carolina Republican, made the following announcement on Tuesday:
Grateful to announce that I am drafting legislation to direct the Bureau of Graving and Printing to design a $250 bill featuring Donald J. Trump. Bidenflation has destroyed the economy forcing American families to carry more cash. Most valuable bill for most valuable President!
We were sad to learn of the death Wednesday of Oscar-winning actor Gene Hackman at the age of 95. Hackman—who starred in Bonnie and Clyde, The French Connection, Mississippi Burning, and several other classic films—became known as a veritable Hollywood everyman over the course of his four-decade career. It was an unforgettable performance as Sheriff 'Little Bill' Daggett in Clint Eastwood's 1992 revisionist Western, Unforgiven, that secured Hackman his second Academy Award.
In the newsletters: Scott Linciccome unpacked the false assumptions underlying fears of a 'retail apocalypse,' Jonah Goldberg argued that not considering Donald Trump's motives misses the forest for the trees, and Nick Catoggio explored the strange decline of pro-Palestinian activism.
On the podcasts: Jonah is joined by Christopher Scalia on The Remnant to discuss the value great books can offer the conservative movement, and Sarah Isgur is joined by Judges Charles Eskridge and Brantley Starr on Advisory Opinions to discuss executive powers and all things Texas.
On the site: Kevin Williamson reports from Dallas on the current strange moment for oil and gas industries.
What's your favorite Gene Hackman film and why?

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Entrepreneur
5 hours ago
- Entrepreneur
Entrepreneur UK's London 100: Mamedica
Mamedica is a private clinic with a linked pharmacy specialising in cannabis-based prescriptions (from oil to cannabis flower) Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. Industry: Health and wellness Mamedica is a private clinic with a linked pharmacy specialising in cannabis-based prescriptions (from oil to cannabis flower). In the last year alone, they experienced a 2,000% revenue increase and a 675,000% growth since inception in their patient base, reflecting the urgent need for alternative treatments. Founded by Jon Robson, and launched in 2022, Mamedica aims to deliver a quality of service which is currently lacking in the medical cannabis sector. Mamedica puts patient safety, security, and satisfaction at the forefront of every activity, using only the most high-calibre consultants and support staff as part of their team. Following a secure, private video consultation the medicines can be delivered directly to the patient's door via next-day delivery service. All medications prescribed by Mamedica are produced and manufactured according to the pharmaceutical-grade EU-GMP (Good Manufacturing Practice), the most stringent in the world. Patients can be assured that their medicines are not contaminated with pesticides or adulterants. The medical cannabis market currently has north of 50,000 patients in the market - expected to rise to 300,000 plus by 2028. The UK's medical cannabis market was valued at approximately £188m in 2023 and is projected to exceed £470m by 2027. Around 60% of their patients seek treatment for psychological or neurological conditions, while 40% present with pain-related issues. The most common conditions they support include anxiety (21%), depression (13%), chronic pain (12%), back and neck pain (10%), and ADHD (10%).
Yahoo
13 hours ago
- Yahoo
‘Forever chemicals' exposure before birth raises the risk of high blood pressure in teenage years
'Forever chemicals' may be taking their toll on our health before we are even born, new research suggests. Per- and polyfluoroalkyl substances, or PFAS, are a group of chemicals used in everyday products like food packaging and non-stick cookware. They're known as 'forever chemicals' because they don't degrade easily and can build up in the environment – and in our bodies. Scientists have detected PFAS in people's blood, breast milk, semen, livers, and even brains. They suspect these chemicals harm human health, with studies linking them to higher cholesterol, some cancers, and fertility problems, among other issues. The new research adds another complication to that list: high blood pressure during adolescence. Related Forever chemicals: Brussels' mission to clean up Europe's water The analysis followed more than 1,000 children in the US. It used maternal plasma collected shortly after they were born to identify their level of prenatal PFAS exposure, and matched it to doctors' records up until their 18th birthdays. Prenatal exposure to PFAS was linked to a higher risk of developing high blood pressure later in childhood, particularly in the teenage years, according to the study published in the Journal of the American Heart Association. The findings indicate that 'these forever chemicals can have long-lasting and potentially harmful effects that may only become apparent years after birth,' Zeyu Li, the study's lead author and a researcher at Johns Hopkins University in the US, said in a statement. The risk of elevated blood pressure was even higher for boys and Black children with higher PFAS levels at birth, the study found. Related How 'dangerous chemicals' detected in products in the EU could be impacting your health In a surprise to researchers, a handful of forever chemicals were actually linked to lower diastolic, or bottom number, blood pressure in early childhood, though that changed when they entered their teenage years. Evidence on the health effects of PFAS has been mixed so far. While researchers believe these chemicals pose risks, it's difficult to pinpoint their exact impact because there are thousands of PFAS that could all interact in different ways, and because people's exposure changes over time. Even so, Li said the latest study underscores the need for researchers to track people's health and their PFAS levels over a long period of time, from early childhood to adolescence and beyond. Related How to avoid 'forever chemicals': 5 items you should stop using to minimise exposure to PFAS Meanwhile, Mingyu Zhang, the study's senior author and an assistant professor at Harvard Medical School, said stronger environmental protections are needed to protect people from PFAS, given they are so ubiquitous that people cannot meaningfully limit their exposure on their own. That could include phasing out forever chemicals from consumer products and in industrial settings, he said, as well as better surveillance and limits on PFAS in water systems. 'This is not something individuals can solve on their own,' Zhang said.
Yahoo
13 hours ago
- Yahoo
The European Commission Approves Alnylam's AMVUTTRA
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential. It declared on June 9, 2025, that AMVUTTRA® (vutrisiran) has been approved by the European Commission to treat wild-type or hereditary ATTR amyloidosis with cardiomyopathy (ATTR-CM). A researcher studying genetic medicines under a microscope in a biopharmaceutical laboratory. As a result, AMVUTTRA is the first and only RNAi treatment approved in the EU for transthyretin amyloidosis symptoms that show as cardiomyopathy and polyneuropathy. The HELIOS-B Phase 3 research, which revealed a 36% mortality reduction over 42 months and a 28% decrease in all-cause mortality and recurrent cardiovascular events, served as the basis for the approval. More than 6,000 patient-years of safety data support the quarterly administration of the medication. The drug is already authorized in Brazil and the United States. Up to 100,000 individuals in Europe have ATTR amyloidosis, mostly as cardiomyopathy. An RNAi treatment called vutrisiran provides continuous knockdown by stopping TTR production at its source with quarterly injections. Functional and quality-of-life gains were validated by the HELIOS-B trial, which involved patients on SGLT2 inhibitors and tafamidis. Elevations of liver enzymes and injection site responses are frequent adverse effects. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is an innovator in the investigation of RNA interference medicines. While we acknowledge the potential of ALNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data